Equity Overview
Price & Market Data
Price: $3.44
Daily Change: -$0.08 / 2.33%
Range: $3.44 - $3.44
Market Cap: $3,056,817
Volume: 917
Performance Metrics
1 Week: 1.00%
1 Month: 0.28%
3 Months: -8.90%
6 Months: -51.67%
1 Year: -76.05%
YTD: -48.69%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.